Ribonuclease inhibitor as an intracellular sentry

Related Experiment Video

Updated: Sep 27, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
12:47

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

Published on: November 3, 2014

Marcia C Haigis1, Erin L Kurten, Ronald T Raines

  • 1Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA.

Nucleic Acids Research
|February 1, 2003
PubMed

Insights

Onconase (ONC) and RNase A variants show increased toxicity in rapidly growing cells. Ribonuclease inhibitor protein (RI) constrains RNase A but not Onconase, offering insights for ribonuclease-based cancer chemotherapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Onconase (ONC), an RNase A homolog, is investigated as a cancer therapeutic.
  • The efficacy of ONC and RNase A variants depends on evading the ribonuclease inhibitor protein (RI) to degrade cellular RNA.

Purpose of the Study:

  • To investigate the relationship between cell growth rate and the cytotoxicity of ONC and RNase A variants.
  • To determine the role of the ribonuclease inhibitor protein (RI) in modulating the cytotoxic effects of these ribonucleases.

Main Methods:

  • Comparative analysis of cytotoxicity of ONC and RNase A variants in cells with varying growth rates.
  • Assessment of RI levels in cells.
  • Evaluation of RI overproduction effects on RNase A variant and ONC cytotoxicity.

Main Results:

  • Cytotoxicity of both ONC and RNase A variants is enhanced in more rapidly growing cells.
  • Endogenous RI levels remain constant across different cell growth rates.
  • Overproducing RI reduces the potency of toxic RNase A variants but does not affect ONC cytotoxicity.

Conclusions:

  • RI acts as a constraint on the cytotoxicity of RNase A variants.
  • ONC's cytotoxicity is independent of RI levels, suggesting a different mechanism of action or evasion.
  • These findings provide crucial insights for developing optimized ribonuclease-based cancer therapies.

More Related Videos

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing (RIPiT-Seq)09:26

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing (RIPiT-Seq)

Published on: July 10, 2019

Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution10:53

Isolation of Cognate RNA-protein Complexes from Cells Using Oligonucleotide-directed Elution

Published on: January 16, 2017

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...